Aligos Therapeutics, Inc. (ALGS) Reports Material Event to SEC
Aligos Therapeutics, Inc. (NASDAQ:ALGS) filed a Form 8-K with the Securities and Exchange Commission on March 05, 2026, disclosing a material event. Aligos Therapeutics, Inc.'s…
Read more
